Inflammatory Cancer-associated Fibroblast-derived Fibronectin Promotes Oxaliplatin Resistance in Pancreatic Ductal Adenocarcinoma through Integrin-mediated Signaling
MEDS Basic Medicine · 2026 · 4 (1)
DOI: 10.23977/medbm.2026.040109 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDS Basic Medicine, 2026.
Abstract (Originalsprache)
: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense fibrotic stroma. Inflammatory cancer-associated fibroblasts (iCAFs) within this stroma have been implicated in tumor progression, but their role in oxaliplatin resistance remains poorly defined. Here, we isolated iCAFs from oxaliplatin-resistant tumors and identified fibronectin (FN1) as a highly upregulated secretory factor through RNA sequencing. Recombinant FN1 and iCAF-conditioned medium significantly attenuated oxaliplatin-induced cytotoxicity in Panc-1 and MIAPaCa-2 cells, while an anti-FN1 neutralizing antibody reversed the protective effect. Bioinformatic analysis of the GSE79669 dataset revealed elevated FN1 and ITGA3 expression in oxaliplatin-resistant pancreatic cancer cells, and high ITGA3 expression was associated with worse overall and disease-free survival in the TCGA cohort. Pathway enrichment analysis of FN1/ITGA3-coexpressed genes identified focal adhesion, ECM-receptor interaction, PI3K-Akt signaling, regulation of actin cytoskeleton, Rap1 signaling, and Hippo signaling as potentially involved downstream pathways. A protein-protein interaction network further highlighted key nodes within these pathways. These findings demonstrate that iCAF-derived FN1 promotes oxaliplatin resistance in vitro and suggest that ITGA3 integrin signaling may mediate this effect, providing a foundation for future therapeutic targeting of stromal-tumor interactions in pancreatic cancer
Zitieren
APA
(2026). Inflammatory Cancer-associated Fibroblast-derived Fibronectin Promotes Oxaliplatin Resistance in Pancreatic Ductal Adenocarcinoma through Integrin-mediated Signaling. MEDS Basic Medicine, 4(1). https://doi.org/10.23977/medbm.2026.040109
Vancouver
Inflammatory Cancer-associated Fibroblast-derived Fibronectin Promotes Oxaliplatin Resistance in Pancreatic Ductal Adenocarcinoma through Integrin-mediated Signaling. MEDS Basic Medicine. 2026;4(1). doi:10.23977/medbm.2026.040109
BibTeX
@article{euvimed2026,
title = {Inflammatory Cancer-associated Fibroblast-derived Fibronectin Promotes Oxaliplatin Resistance in Pancreatic Ductal Adenocarcinoma through Integrin-mediated Signaling},
journal = {MEDS Basic Medicine},
year = {2026},
volume = {4},
number = {1},
doi = {10.23977/medbm.2026.040109}
}
EUVIMED